Literature DB >> 2069508

The genetic aspects of influenza virus filamentous particle formation.

M A Kuznetsova, N V Kaverin.   

Abstract

We analysed the genetic content of reassortants between parent viruses differing in their ability to form filaments. The results suggest that primarily HA, M, and NP genes are involved in the control of the filament forming ability. A lower buoyant density of the filamentous forms as compared to spherical particles allowed us to obtain a sufficiently pure population of filaments. A difference in the UV-inactivation kinetics between filaments and spherical virions suggests that the infectious filamentous forms are probably represented by multigenomic particles or partial heterozygotes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2069508     DOI: 10.1007/BF01314038

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  2 in total

1.  Natural heterogeneity of shape, infectivity and protein composition in an influenza A (H3N2) virus preparation.

Authors:  R W Ruigrok; P C Krijgsman; F M de Ronde-Verloop; J C de Jong
Journal:  Virus Res       Date:  1985-07       Impact factor: 3.303

2.  Human-avian influenza virus reassortants: effect of reassortment pattern on multi-cycle reproduction in MDCK cells.

Authors:  N V Kaverin; I A Rudneva; Y A Smirnov; N N Finskaya
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

  2 in total
  18 in total

1.  Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.

Authors:  H Jin; G P Leser; J Zhang; R A Lamb
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

2.  Single-particle measurements of filamentous influenza virions reveal damage induced by freezing.

Authors:  Jack C Hirst; Edward C Hutchinson
Journal:  J Gen Virol       Date:  2019-12       Impact factor: 3.891

3.  Host cell dependence of viral morphology.

Authors:  P C Roberts; R W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

4.  Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus.

Authors:  Seema S Lakdawala; Elaine W Lamirande; Amorsolo L Suguitan; Weijia Wang; Celia P Santos; Leatrice Vogel; Yumiko Matsuoka; William G Lindsley; Hong Jin; Kanta Subbarao
Journal:  PLoS Pathog       Date:  2011-12-29       Impact factor: 6.823

5.  Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G.

Authors:  T Mebatsion; F Weiland; K K Conzelmann
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

6.  A crucial role of N-terminal domain of influenza A virus M1 protein in interaction with swine importin α1 protein.

Authors:  Qinfang Liu; Bhupinder Bawa; Jingjiao Ma; Feng Li; Wenjun Ma; Jürgen A Richt
Journal:  Virus Genes       Date:  2014-04-18       Impact factor: 2.332

7.  The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication.

Authors:  L J Mitnaul; M R Castrucci; K G Murti; Y Kawaoka
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology.

Authors:  Lisa Z Scheifele; Scott P Kenney; Tina M Cairns; Rebecca C Craven; Leslie J Parent
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

9.  Influenza a viruses with mutations in the m1 helix six domain display a wide variety of morphological phenotypes.

Authors:  Laura M Burleigh; Lesley J Calder; John J Skehel; David A Steinhauer
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 10.  Filamentous influenza viruses.

Authors:  Bernadeta Dadonaite; Swetha Vijayakrishnan; Ervin Fodor; David Bhella; Edward C Hutchinson
Journal:  J Gen Virol       Date:  2016-06-30       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.